INVO Bioscience Statistics Share Statistics INVO Bioscience has 3.91M
shares outstanding. The number of shares has increased by 0%
in one year.
Shares Outstanding 3.91M Shares Change (YoY) 0% Shares Change (QoQ) 0% Owned by Institutions (%) 0.84% Shares Floating 3.88M Failed to Deliver (FTD) Shares 214 FTD / Avg. Volume 0.02%
Short Selling Information The latest short interest is 1.06M, so 0% of the outstanding
shares have been sold short.
Short Interest 1.06M Short % of Shares Out n/a Short % of Float n/a Short Ratio (days to cover) 1
Valuation Ratios PE Ratio 0 Forward PE 4.38 PS Ratio 0 Forward PS 0.1 PB Ratio 0 P/FCF Ratio 0 PEG Ratio 0
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for INVO Bioscience.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 0.07,
with a Debt / Equity ratio of 0.85.
Current Ratio 0.07 Quick Ratio 0.06 Debt / Equity 0.85 Debt / EBITDA -1.13 Debt / FCF -3.62 Interest Coverage 7.69
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $261.28M Profits Per Employee $-373.86M Employee Count 25 Asset Turnover 0.14 Inventory Turnover 16.64
Taxes Income Tax -22.91M Effective Tax Rate 0.25%
Stock Price Statistics The stock price has increased by -7.69% in the
last 52 weeks. The beta is 1.44, so INVO Bioscience's
price volatility has been higher than the market average.
Beta 1.44 52-Week Price Change -7.69% 50-Day Moving Average 0.78 200-Day Moving Average 0.9 Relative Strength Index (RSI) 48.55 Average Volume (20 Days) 1,149,370
Income Statement In the last 12 months, INVO Bioscience had revenue of 6.53B
and earned -9.35B
in profits. Earnings per share was -3019.48.
Revenue 6.53B Gross Profit 2.87B Operating Income -8.13B Net Income -9.35B EBITDA -9.51B EBIT n/a Earnings Per Share (EPS) -3019.48
Full Income Statement Balance Sheet The company has 741.4M in cash and 10.78B in
debt, giving a net cash position of -10.03B.
Cash & Cash Equivalents 741.4M Total Debt 10.78B Net Cash -10.03B Retained Earnings -67.16B Total Assets 31.74B Working Capital -17.15B
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -2.97B
and capital expenditures 0, giving a free cash flow of -2.97B.
Operating Cash Flow -2.97B Capital Expenditures n/a Free Cash Flow -2.97B FCF Per Share -960.91
Full Cash Flow Statement Margins Gross margin is 44%, with operating and profit margins of -124.4% and -143.09%.
Gross Margin 44% Operating Margin -124.4% Pretax Margin -139.6% Profit Margin -143.09% EBITDA Margin -145.53% EBIT Margin -124.4% FCF Margin -45.54%
Dividends & Yields INVO does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast Currently there are no analyst rating for INVO.
Price Target n/a Price Target Difference n/a Analyst Consensus n/a Analyst Count n/a
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Jul 28, 2023. It was a
backward
split with a ratio of 1:20.
Last Split Date Jul 28, 2023 Split Type backward Split Ratio 1:20
Scores Altman Z-Score -7 Piotroski F-Score 4
